CareSignal Earns 93.2% Performance Score in KLAS Research Remote Patient Monitoring ReportJune 23, 2023 / Nueterra Capital Marketing
CareSignal, the remote patient monitoring device from Nueterra Capital portfolio company Lightbeam Health Solutions, has received a 93.2% overall performance score in the limited data segment of KLAS Research’s 2023 Remote Patient Monitoring Report. The score was based on responses from 10 individuals in 9 organizations; the respondents “tend to be highly satisfied, describing the vendor as extremely responsive and accommodating.” CareSignal’s score exceeded the overall vendor average score of 85%.
CareSignal is unique from other remote patient monitoring platforms because it uses text messages and phone calls, instead of requiring patients to learn to use a new device. CareSignal is currently used for monitoring over 30 health conditions, including COPD, diabetes, and depression.
“This is the first time CareSignal has been included in a report by KLAS Research, and we are humbled and energized to have achieved the highest score of any RPM company assessed,” said Blake Marggraff, CEO of Lightbeam’s CareSignal division in a press release issued by the company.